Skip to main content
STRO logo

STRO · Sutro Biopharma, Inc.

$23.40 +0.40 (+1.74%) At close · Jul 22
Market Cap
$387.75M
Shares
16.57M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
56/100
Short interest 8.2% of shares — P85 Days to cover 2.3 — P50 Price vs VWAP -23.4% — P14 Short-volume trend -4.5% — P34 Short interest change +47.7% — P88 Worst FTD 0.01% of shares — P44

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 1,361,955 922,188 +439,767 2.31
2026-06-15 922,188 751,365 +170,823 3.90
2026-05-29 751,365 1,193,156 -441,791 1.73
2026-05-15 1,193,156 977,108 +216,048 5.61
2026-04-30 977,108 748,699 +228,409 3.91
2026-04-15 748,699 639,714 +108,985 2.88
2026-03-31 639,714 532,614 +107,100 2.79
2026-03-13 532,614 517,388 +15,226 3.17
2026-02-27 517,388 645,074 -127,686 5.15
2026-02-13 645,074 591,301 +53,773 4.43
2026-01-30 591,301 528,233 +63,068 5.03
2026-01-15 528,233 404,777 +123,456 4.03
2025-12-31 404,777 560,264 -155,487 3.72
2025-12-15 560,264 3,977,435 -3,417,171 4.01
2025-11-28 397,744 352,161 +45,582 6.34
2025-11-14 352,161 339,324 +12,838 4.29
2025-10-31 339,324 250,658 +88,665 1.47
2025-10-15 250,658 248,486 +2,172 4.41
2025-09-30 248,486 251,782 -3,295 5.87
2025-09-15 251,782 311,109 -59,328 3.67
2025-08-29 311,109 352,990 -41,880 7.81
2025-08-15 352,990 338,390 +14,600 9.73
2025-07-31 338,390 366,014 -27,624 5.82
Showing 1–23 of 23 settlements
Key facts CIK 1382101 CUSIP 869367201 13F (30d) 4 filings 4 filers Visit website Investor relations